05th February 2020

Boardroom appointment at Creo Medical

A non-executive director with extensive experience in corporate finance has been appointed to the board at Creo Medical Group.

Ivonne Cantu has joined the medical device company which is focused on the emerging field of surgical endoscopy.

Cantu has acted as a corporate finance adviser to UK and international companies for more than 20 years at Cenkos Securities and previously at Merrill Lynch.

She is currently director of investor relations and corporate development at Benchmark Holdings, an AIM-listed aquaculture technology company.

Creo chairman Charles Spicer said: “We are pleased to welcome Ivonne to the board.

“She has known Creo since we were a private company and brings a wealth of experience from her career in the City, which we are confident will make a major contribution to the success of Creo.”